AdaptHealth (NASDAQ:AHCO) Major Shareholder Buys $4,430,761.00 in Stock

AdaptHealth Corp. (NASDAQ:AHCO) major shareholder Richard Cashin, Jr. purchased 447,100 shares of the firm’s stock in a transaction on Friday, March 20th. The stock was acquired at an average price of $9.91 per share, for a total transaction of $4,430,761.00. Following the transaction, the insider owned 16,312,698 shares of the company’s stock, valued at $161,658,837.18. The trade was a 2.82% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

AdaptHealth Price Performance

Shares of NASDAQ:AHCO opened at $11.39 on Thursday. The company has a market capitalization of $1.55 billion, a PE ratio of -20.71, a price-to-earnings-growth ratio of 1.32 and a beta of 1.76. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.81 and a current ratio of 1.02. The stock has a fifty day moving average of $10.13 and a 200-day moving average of $9.75. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.75.

AdaptHealth (NASDAQ:AHCO) last issued its earnings results on Tuesday, February 24th. The company reported ($0.76) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($1.10). AdaptHealth had a positive return on equity of 3.42% and a negative net margin of 2.18%.The company had revenue of $846.29 million during the quarter, compared to analyst estimates of $832.51 million. During the same quarter in the previous year, the firm earned $0.34 earnings per share. The business’s revenue was down 1.2% compared to the same quarter last year. As a group, equities analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current fiscal year.

Trending Headlines about AdaptHealth

Here are the key news stories impacting AdaptHealth this week:

• Positive Sentiment: Major insider buy — Richard M. Cashin Jr., a >10% holder, purchased 447,100 shares (~$4.43M) at about $9.91 per share, increasing his stake and signaling insider confidence in the business. Insider Buying: AdaptHealth Major Shareholder Purchases 447,100 Shares
• Positive Sentiment: Technical/momentum lift — several outlets report AHCO surged to a new 12‑month high and registered strong relative strength, which attracts momentum traders and ETFs that use RS screens. AdaptHealth Surges To New High
• Positive Sentiment: Institutional accumulation highlighted — reports show several hedge funds/institutions have been increasing positions in AHCO, supporting longer-term demand and liquidity (MarketBeat coverage). AdaptHealth Institutional Ownership & Coverage
• Neutral Sentiment: Analyst picture is mixed — consensus is a “Moderate Buy” with an average target around $13.25, but recent rating/price target tweaks are varied, so analyst action is not uniformly bullish. Analyst Ratings Summary
• Negative Sentiment: Zacks caution — Zacks flagged a 10.7% surge on above‑average volume but noted that recent earnings‑estimate revision trends don’t support sustained upside, implying the rally could be partly technical rather than fundamental. Zacks: AHCO Surges 10.7%
• Negative Sentiment: Rising short interest — reports show a notable increase in short positions in March (~9.04M shares in one report, ≈6.8% of float, ~5.1 days to cover), which can pressure the stock if fundamentals disappoint but also raises squeeze potential during rallies. (Short interest data aggregated from recent filings/reports.)

Hedge Funds Weigh In On AdaptHealth

Institutional investors and hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of AdaptHealth by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock worth $656,000 after acquiring an additional 2,564 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in AdaptHealth by 32.4% during the first quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock valued at $6,192,000 after purchasing an additional 139,828 shares during the last quarter. Woodline Partners LP purchased a new position in AdaptHealth in the first quarter valued at about $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in AdaptHealth by 18.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock valued at $2,534,000 after purchasing an additional 35,879 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in AdaptHealth by 6.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock worth $256,000 after purchasing an additional 1,671 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AHCO has been the subject of a number of analyst reports. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Weiss Ratings downgraded shares of AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research report on Wednesday, February 25th. Leerink Partners cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, February 26th. Wall Street Zen downgraded shares of AdaptHealth from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $13.00 price objective on shares of AdaptHealth in a research note on Wednesday, February 25th. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, AdaptHealth has an average rating of “Moderate Buy” and a consensus target price of $13.25.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.